rs117751000 (DLG2): bone mineral density link

Key takeaways

  • This variant is linked to changes in bone mineral density and uric acid levels.
  • The effect size reported is 2.69 with high significance p=3e-8.
  • Association found in a genome-wide association study of about 4 thousand individuals.

Key takeaways

  • This variant is linked to changes in bone mineral density and uric acid levels.
  • The effect size reported is 2.69 with high significance p=3e-8.
  • Association found in a genome-wide association study of about 4 thousand individuals.

What the research says This variant is associated with a change in femur bone mineral density and serum urate levels interaction, reported effect size 2.69 p=3e-8 PMID 34046847. The association was observed in a genome-wide association study of about 4 thousand individuals PMID 34046847.

Reported associations Femur bone mineral density: this variant is associated with a change in femur bone mineral density interaction reported effect size 2.69 p=3e-8 PMID 34046847 Serum urate levels: this variant is associated with a change in serum urate levels interaction reported effect size 2.69 p=3e-8 PMID 34046847

Evidence quality The association was reported in a genome-wide association study of about 4 thousand individuals with an effect size of 2.69 and p=3e-8 PMID 34046847. No other studies were provided so replication status is unknown.

No lifestyle considerations on file for this variant.

Frequently asked questions

What does rs117751000 mean?

It is a genetic variant linked to changes in bone mineral density and uric acid levels with an effect size of 2.69 p=3e-8.

Is this variant related to gout?

The study shows the variant is associated with serum urate levels, which can influence gout risk.

Can I get a health report from this?

Consumer DNA tests may include this SNP but they do not provide personalized health advice.